PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 158 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $499,000 | -27.7% | 131,308 | -3.1% | 0.00% | 0.0% |
| Q4 2019 | $690,000 | +0.7% | 135,472 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $685,000 | -15.2% | 135,472 | +3.5% | 0.00% | -50.0% |
| Q2 2019 | $808,000 | +34.9% | 130,944 | +1.4% | 0.00% | +100.0% |
| Q1 2019 | $599,000 | +7.9% | 129,169 | -2.2% | 0.00% | 0.0% |
| Q4 2018 | $555,000 | -31.1% | 132,132 | +2.9% | 0.00% | -50.0% |
| Q3 2018 | $805,000 | -11.8% | 128,352 | +13.1% | 0.00% | 0.0% |
| Q2 2018 | $913,000 | +13.6% | 113,510 | +5.4% | 0.00% | 0.0% |
| Q1 2018 | $804,000 | +21.3% | 107,734 | -3.4% | 0.00% | +100.0% |
| Q4 2017 | $663,000 | -20.3% | 111,510 | -1.4% | 0.00% | -50.0% |
| Q3 2017 | $832,000 | -2.2% | 113,049 | -9.8% | 0.00% | 0.0% |
| Q2 2017 | $851,000 | -34.2% | 125,311 | -8.6% | 0.00% | -33.3% |
| Q1 2017 | $1,294,000 | +4.4% | 137,111 | -4.5% | 0.00% | 0.0% |
| Q4 2016 | $1,240,000 | +33.2% | 143,511 | -2.4% | 0.00% | +50.0% |
| Q3 2016 | $931,000 | +52.1% | 147,011 | +1.4% | 0.00% | +100.0% |
| Q2 2016 | $612,000 | -4.8% | 145,011 | -1.7% | 0.00% | 0.0% |
| Q1 2016 | $643,000 | -18.7% | 147,511 | +14.3% | 0.00% | -50.0% |
| Q4 2015 | $791,000 | +9.1% | 129,055 | +1.8% | 0.00% | 0.0% |
| Q3 2015 | $725,000 | -23.6% | 126,798 | -0.3% | 0.00% | 0.0% |
| Q2 2015 | $949,000 | +25.0% | 127,198 | +0.2% | 0.00% | 0.0% |
| Q1 2015 | $759,000 | -22.2% | 126,983 | -1.6% | 0.00% | 0.0% |
| Q4 2014 | $975,000 | +46.2% | 128,983 | +0.4% | 0.00% | 0.0% |
| Q3 2014 | $667,000 | +21.9% | 128,434 | +1.1% | 0.00% | +100.0% |
| Q2 2014 | $547,000 | +7.7% | 127,005 | +2.3% | 0.00% | 0.0% |
| Q1 2014 | $508,000 | -11.7% | 124,105 | +15.1% | 0.00% | -50.0% |
| Q4 2013 | $575,000 | +6.5% | 107,805 | +0.5% | 0.00% | 0.0% |
| Q3 2013 | $540,000 | +36.0% | 107,305 | +20.7% | 0.00% | +100.0% |
| Q2 2013 | $397,000 | -7.2% | 88,939 | +12.0% | 0.00% | 0.0% |
| Q1 2013 | $428,000 | – | 79,421 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|